SAMSCA

This brand name is authorized in Austria, Canada, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Italy, Japan, Lithuania, Poland, Romania, Turkey, United Kingdom, United States

Active ingredients

The drug SAMSCA contains one active pharmaceutical ingredient (API):

1 Tolvaptan
UNII 21G72T1950 - TOLVAPTAN

Tolvaptan is a selective vasopressin V2-receptor antagonist that specifically blocks the binding of arginine vasopressin (AVP) at the V2-receptor of the distal portions of the nephron. Tolvaptan affinity for the human V2-receptor is 1.8 times that of native AVP.

Read about Tolvaptan

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
SAMSCA Tablet European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C03XA01 Tolvaptan C Cardiovascular system → C03 Diuretics → C03X Other diuretics → C03XA Vasopressin antagonists
Discover more medicines within C03XA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 02370468, 02370476
Country: EE Ravimiamet Identifier(s): 1433933, 1433944, 1433955, 1433966, 1753624, 1753635, 1847392, 1847404
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 09539001, 09539003, 109539007
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 038376, 038399, 165319, 553802
Country: FR Base de données publique des médicaments Identifier(s): 63371428, 63790853, 67412139
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 159346, 159352, 367567
Country: HK Department of Health Drug Office Identifier(s): 59910, 59911
Country: IT Agenzia del Farmaco Identifier(s): 039551015, 039551027, 039551039, 039551041, 039551054, 039551066, 039551078, 039551080
Country: JP 医薬品医療機器総合機構 Identifier(s): 2139011D1022, 2139011F3026, 2139011F4022, 2499012F2029
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1050734, 1050735, 1050736, 1050737, 1084008, 1084009, 1086390, 1086391
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100316415, 100316421, 100417553
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W67142001, W67142002, W67143001, W67143002
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8680683010019, 8680683010026, 8680683010033, 8680683010040
Country: US FDA, National Drug Code Identifier(s): 59148-020, 59148-021

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.